Advertisement

Topics

"Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)" Drugs and Medication Database

06:49 EST 23rd January 2019 | BioPortfolio

Here are the most relevant "Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)" Drugs and Medications that we have found in our database.

More Information about "Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)" on BioPortfolio

We have published hundreds of Chronic Kidney Disease in Children Prospective Cohort Study (CKiD) news stories on BioPortfolio along with dozens of Chronic Kidney Disease in Children Prospective Cohort Study (CKiD) Clinical Trials and PubMed Articles about Chronic Kidney Disease in Children Prospective Cohort Study (CKiD) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chronic Kidney Disease in Children Prospective Cohort Study (CKiD) Companies in our database. You can also find out about relevant Chronic Kidney Disease in Children Prospective Cohort Study (CKiD) Drugs and Medications on this site too.

Showing "Chronic Kidney Disease Children Prospective Cohort Study CKiD" Drugs and Medications, all 5

Possibly Relevant

Niacor [Avondale Pharmaceuticals, LLC]

NIACOR (Niacin Tablets, USP) 500 mg

Niacor [Upsher-Smith Laboratories, LLC]

NIACOR (Niacin Tablets, USP)500 mg

Yasmin [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001

Descovy [REMEDYREPACK INC.]

These highlights do not include all the information needed to use DESCOVY safely and effectively. See full prescribing information for DESCOVY. DESCOVY (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015

Descovy [Gilead Sciences, Inc.]

These highlights do not include all the information needed to use DESCOVY safely and effectively. See full prescribing information for DESCOVY. DESCOVY (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015



Advertisement
Quick Search
Advertisement
Advertisement